Daniel Bruetman

Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology

Nasser H. Hanna, Marcus A. Neubauer, Constantin T. Yiannoutsos et al. · Journal of Clinical Oncology · 2008 · 496 citations

Medicine, Oncology, Radiation Oncology +15

Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology

Shadia I. Jalal, Heather Riggs, A. Melnyk et al. · Annals of Oncology · 2011 · 79 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable stage III non-small cell lung cancer (NSCLC): HOG LUN 01–24/USO-023

Nasser H. Hanna, M. Neubauer, Rafat Ansari et al. · Journal of Clinical Oncology · 2007 · 60 citations

Medicine, Oncology, Radiation Oncology +17

Pemetrexed in Second Line and beyond Small Cell Lung Cancer: A Hoosier Oncology Group Phase II Study

Shadia I. Jalal, Rafat Ansari, Ramaswamy Govindan et al. · Journal of Thoracic Oncology · 2009 · 30 citations · Full text

Medicine, Oncology, Pharmacology +9

Gefitinib Plus Celecoxib in Chemotherapy-Naïve Patients with Stage IIIB/IV Non-small Cell Lung Cancer: A Phase II Study from the Hoosier Oncology Group

Anuj K. Agarwala, William B. Fisher, Daniel Bruetman et al. · Journal of Thoracic Oncology · 2008 · 23 citations · Full text

Medicine, Oncology, Pharmacology +13